Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patients.
Poddubskaya E, Suntsova M, Lyadova M, Luppov D, Guryanova A, Lyadov V, Garazha A, Sorokin M, Semenova A, Shatalov V, Biakhova M, Simonov A, Moisseev A, Buzdin A. Poddubskaya E, et al. Front Immunol. 2024 Dec 12;15:1493877. doi: 10.3389/fimmu.2024.1493877. eCollection 2024. Front Immunol. 2024. PMID: 39723204 Free PMC article.
A New Approach of Detecting ALK Fusion Oncogenes by RNA Sequencing Exon Coverage Analysis.
Zakharova G, Suntsova M, Rabushko E, Mohammad T, Drobyshev A, Seryakov A, Poddubskaya E, Moisseev A, Smirnova A, Sorokin M, Tkachev V, Simonov A, Guguchkin E, Karpulevich E, Buzdin A. Zakharova G, et al. Among authors: poddubskaya e. Cancers (Basel). 2024 Nov 16;16(22):3851. doi: 10.3390/cancers16223851. Cancers (Basel). 2024. PMID: 39594806 Free PMC article.
Bioinformatic and clinical experimental assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new combined and individual survival biomarkers outperforming MGMT promoter methylation.
Modestov A, Zolotovskaia M, Suntsova M, Zakharova G, Seryakov A, Jovcevska I, Mlakar J, Poddubskaya E, Moisseev A, Vykhodtsev G, Roumiantsev S, Sorokin M, Tkachev V, Simonov A, Buzdin A. Modestov A, et al. Among authors: poddubskaya e. Ther Adv Med Oncol. 2024 Nov 8;16:17588359241292269. doi: 10.1177/17588359241292269. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39525666 Free PMC article.
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.
Ahn MJ, Tanaka K, Paz-Ares L, Cornelissen R, Girard N, Pons-Tostivint E, Vicente Baz D, Sugawara S, Cobo M, Pérol M, Mascaux C, Poddubskaya E, Kitazono S, Hayashi H, Hong MH, Felip E, Hall R, Juan-Vidal O, Brungs D, Lu S, Garassino M, Chargualaf M, Zhang Y, Howarth P, Uema D, Lisberg A, Sands J; TROPION-Lung01 Trial Investigators. Ahn MJ, et al. Among authors: poddubskaya e. J Clin Oncol. 2024 Sep 9:JCO2401544. doi: 10.1200/JCO-24-01544. Online ahead of print. J Clin Oncol. 2024. PMID: 39250535
Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (TERT) gene expression status.
Drobyshev A, Modestov A, Suntsova M, Poddubskaya E, Seryakov A, Moisseev A, Sorokin M, Tkachev V, Zakharova G, Simonov A, Zolotovskaia MA, Buzdin A. Drobyshev A, et al. Among authors: poddubskaya e. Front Genet. 2024 May 27;15:1401100. doi: 10.3389/fgene.2024.1401100. eCollection 2024. Front Genet. 2024. PMID: 38859942 Free PMC article.
Sample-Wise and Gene-Wise Comparisons Confirm a Greater Similarity of RNA and Protein Expression Data at the Level of Molecular Pathways and Suggest an Approach for the Data Quality Check in High-Throughput Expression Databases.
Raevskiy M, Sorokin M, Emelianova A, Zakharova G, Poddubskaya E, Zolotovskaia M, Buzdin A. Raevskiy M, et al. Among authors: poddubskaya e. Biochemistry (Mosc). 2024 Apr;89(4):737-746. doi: 10.1134/S0006297924040126. Biochemistry (Mosc). 2024. PMID: 38831509
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ, Oh DY, Kato K, Arkenau T, Tabernero J, Correa MC, Zimina AV, Bai Y, Shi J, Lee KW, Wang J, Poddubskaya E, Pan H, Rha SY, Zhang R, Hirano H, Spigel D, Yamaguchi K, Chao Y, Wyrwicz L, Disel U, Cid RP, Fornaro L, Evesque L, Wang H, Xu Y, Li J, Sheng T, Yang S, Li L, Moehler M, Xu RH; RATIONALE-305 Investigators. Qiu MZ, et al. Among authors: poddubskaya e. BMJ. 2024 May 28;385:e078876. doi: 10.1136/bmj-2023-078876. BMJ. 2024. PMID: 38806195 Clinical Trial.
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
Spigel DR, Dowlati A, Chen Y, Navarro A, Yang JC, Stojanovic G, Jove M, Rich P, Andric ZG, Wu YL, Rudin CM, Chen H, Zhang L, Yeung S, Benzaghou F, Paz-Ares L, Bunn PA; RESILIENT Trial Investigators. Spigel DR, et al. J Clin Oncol. 2024 Jul 1;42(19):2317-2326. doi: 10.1200/JCO.23.02110. Epub 2024 Apr 22. J Clin Oncol. 2024. PMID: 38648575 Free PMC article. Clinical Trial.
A single-lead ECG based cardiotoxicity detection in patients on polychemotherapy.
Mesitskaya DF, Fashafsha ZZA, Poltavskaya MG, Andreev DA, Levshina AR, Sultygova EA, Gognieva D, Chomakhidze P, Kuznetsova N, Suvorov A, Marina I S, Poddubskaya E, Novikova A, Bykova A, Kopylov P. Mesitskaya DF, et al. Among authors: poddubskaya e. Int J Cardiol Heart Vasc. 2024 Jan 20;50:101336. doi: 10.1016/j.ijcha.2024.101336. eCollection 2024 Feb. Int J Cardiol Heart Vasc. 2024. PMID: 38304727 Free PMC article.
58 results